Donghyun (Raphael) Park has joined the Scripps Research Fellows Program to develop new ways of addressing tuberculosis, a curable and preventable disease that nevertheless kills an estimated 1.5 million people each year, according to the World Health Organization.
While completing his doctorate in Microbiology at Yale University, Park established an innovative, high-throughput, cryo-electron tomography (cryo-ET) pipeline to investigate how pathogens create niches within hosts and how the immune system neutralizes the invader. In his lab at Scripps Research, he continues to employ his cryo-ET imaging innovations to reveal how bacterial nanomachinery causes infection. His ultimate goal is to identify new targets and design new antibacterial medicines.
Share
